» Articles » PMID: 33535618

Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Feb 4
PMID 33535618
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Surgery is the mainstay of treatment for localized soft tissue sarcomas (STS). The curative treatment highly depends on complete tumor resection, as positive margins are associated with local recurrence (LR) and prognosis. However, determining the tumor margin during surgery is challenging. Real-time tumor-specific imaging can facilitate complete resection by visualizing tumor tissue during surgery. Unfortunately, STS specific tracers are presently not clinically available. In this review, STS-associated cell surface-expressed biomarkers, which are currently already clinically targeted with monoclonal antibodies for therapeutic purposes, are evaluated for their use in near-infrared fluorescence (NIRF) imaging of STS. Clinically targeted biomarkers in STS were extracted from clinical trial registers and a PubMed search was performed. Data on biomarker characteristics, sample size, percentage of biomarker-positive STS samples, pattern of biomarker expression, biomarker internalization features, and previous applications of the biomarker in imaging were extracted. The biomarkers were ranked utilizing a previously described scoring system. Eleven cell surface-expressed biomarkers were identified from which 7 were selected as potential biomarkers for NIRF imaging: TEM1, VEGFR-1, EGFR, VEGFR-2, IGF-1R, PDGFRα, and CD40. Promising biomarkers in common and aggressive STS subtypes are TEM1 for myxofibrosarcoma, TEM1, and PDGFRα for undifferentiated soft tissue sarcoma and EGFR for synovial sarcoma.

Citing Articles

Biochemical implications of robotic surgery: a new frontier in the operating room.

Mokhtari L, Hosseinzadeh F, Nourazarian A J Robot Surg. 2024; 18(1):91.

PMID: 38401027 DOI: 10.1007/s11701-024-01861-6.


Cross-species evaluation of fibroblast activation protein alpha as potential imaging target for soft tissue sarcoma: a comparative immunohistochemical study in humans, dogs, and cats.

Beer P, Pauli C, Haberecker M, Grest P, Beebe E, Fuchs D Front Oncol. 2023; 13:1210004.

PMID: 37727209 PMC: 10505752. DOI: 10.3389/fonc.2023.1210004.


Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.

Rijs Z, Belt E, Kalisvaart G, Sier C, Kuppen P, Cleven A Biomedicines. 2023; 11(3).

PMID: 36979961 PMC: 10046284. DOI: 10.3390/biomedicines11030982.


Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors.

Shell D Gen Thorac Cardiovasc Surg. 2023; 71(5):263-271.

PMID: 36631707 DOI: 10.1007/s11748-023-01905-y.


Intraoperative Near-Infrared Fluorescence Imaging with Indocyanine Green for Identification of Gastrointestinal Stromal Tumors (GISTs), a Feasibility Study.

Kalisvaart G, Meijer R, Bijlstra O, Galema H, de Steur W, Hartgrink H Cancers (Basel). 2022; 14(6).

PMID: 35326721 PMC: 8946640. DOI: 10.3390/cancers14061572.


References
1.
Duan C, Li C, Zhao L, Subramaniam S, Yu X, Li Y . Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium. PLoS One. 2016; 11(6):e0156949. PMC: 4902223. DOI: 10.1371/journal.pone.0156949. View

2.
Liu L, Kakiuchi-Kiyota S, Arnold L, Johansson S, Wert D, Cohen S . Pathogenesis of human hemangiosarcomas and hemangiomas. Hum Pathol. 2013; 44(10):2302-11. DOI: 10.1016/j.humpath.2013.05.012. View

3.
Kennedy M, Biddolph S, Lucas S, Howells D, Picton S, Mcgee J . CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma. Mol Pathol. 1999; 52(1):32-6. PMC: 395668. DOI: 10.1136/mp.52.1.32. View

4.
Leibl S, Moinfar F . Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation. Am J Surg Pathol. 2006; 30(4):450-6. DOI: 10.1097/00000478-200604000-00004. View

5.
Harlaar N, Koller M, de Jongh S, van Leeuwen B, Hemmer P, Kruijff S . Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol. 2017; 1(4):283-290. DOI: 10.1016/S2468-1253(16)30082-6. View